INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Addressing Trial Design Hurdles Across Alzheimer's Disease Stages

  Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.

• Don't Just Swap The Engine. Redesign The Factory.

  Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.

• Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers

  For a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.

• How AI Is Reshaping Trial Design, Execution, And Disclosure

  AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.

• Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?

  7/7/2025

  Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.

• How One Market Signal Reframed AI's Value In Early BioTech

  2/17/2026

  Explore how transparent decision-making and operational integrity are redefining value for early-stage life science ventures, navigating the path from discovery to market.

• RTSM Red Flags in Clinical Trials: When It's Time To Switch IRT/RTSM Software

  3/25/2026

  This clip outlines the key warning signs that an RTSM is no longer meeting study needs and offers practical guidance for recognizing risk early and making decisions that support trial continuity.

• It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies

  7/7/2025

  CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.

• Is The Industry Ready To Trust LLMs With Chart Review?

  5/27/2026

  See how LLM-powered extraction transforms unstructured medical records into compliant, audit-ready clinical data with machine-scale speed, human oversight, and regulatory-grade accuracy.